Allogeneic hematopoietic transplantation for mantle-cell lymphoma: Molecular remissions and evidence of graft-versus-malignancy

This publication has 31 references indexed in Scilit:

• Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma.
  Journal of Clinical Oncology, 1998
• High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission.
  Journal of Clinical Oncology, 1998
• Allogeneic Versus Autologous Bone Marrow Transplantation for Refractory and Recurrent Low-Grade Non-Hodgkin's Lymphoma
  Blood, 1997
• Allogeneic blood or marrow transplantation for chronic lymphocytic leukaemia: timing of transplantation and potential effect of fludarabine on acute graft‐versus‐host disease
  British Journal of Haematology, 1997
• Mantle cell lymphoma: correlation of clinical outcome and biologic features with three histologic variants.
  Journal of Clinical Oncology, 1997
• Allogeneic bone marrow transplantation for poor-prognosis lymphoma: Response, toxicity, and survival depend on disease histology
  The American Journal of Medicine, 1996
• Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non-Hodgkin's lymphoma
  Blood, 1994
• Intermediate lymphocytic lymphoma: clinical and pathologic features of a recently characterized subtype of non-Hodgkin's lymphoma.
  Journal of Clinical Oncology, 1993
• Autologous versus allogeneic bone marrow transplantation for non-Hodgkin's lymphoma: a case-controlled analysis of the European Bone Marrow Transplant Group Registry data.
  Journal of Clinical Oncology, 1992
• Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation
  Blood, 1991